retatrutide 32 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Survodutide vs. Retatrutide for Weight

Flush out lactic acid and restore your body with one liter of hydration

Some individuals experience stomach upset after a Lipo-B injection

Kidney Issues Dehydration from nausea and vomiting can put stress on the kidneys

However, Tranont products have not undergone FDA review, and the Proposition 65 settlement regarding lead content raises questions about manufacturing standards

Research Insights Superior Weight Loss Outcomes In a 48-week phase 2 study, adults with obesity treated with retatrutide experienced mean weight reductions of 22.8% (8 mg dose) and 24.2% (12 mg dose), outperforming other weight loss medications